50242-0142 Lunsumio - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50242-0142

Brand Name:

Lunsumio

Generic Name:

Mosunetuzumab

Dosage Form Name:

CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: MOSUNETUZUMAB

Strength: 30.0

Unit: mg/30mL

Packages:

Code: 50242-0142-01

Description: 1 VIAL in 1 CARTON (50242-142-01) / 30 mL in 1 VIAL

Effective Date: Dec. 22, 2022

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD20, CD3

Orphan Drug Designation:

Yes

Status:

In Use